Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellinger

Showing results (711-720 of 963) with videos related to

Pageof 97
Sort By:
Infection and Immunity|June 11, 2014
A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypesConcerta Holley, Dharanesh Gangaiah, Wei Li, et al.
Wiener Klinische Wochenschrift|May 31, 2023
The history of circadian rhythm research in AustriaEva S Schernhammer, Gerhard Klösch, Isabella Ellinger, et al.
Infection and Immunity|May 1, 2019
A Class I <i>Haemophilus ducreyi</i> Strain Containing a Class II <i>hgbA</i> Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy TrialsIsabelle Leduc, Kate R Fortney, Diane M Janowicz, et al.
Urology|February 5, 2008
CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancerJörg Ellinger, Patrick J Bastian, Thomas Jurgan, et al.
Cancer Science|September 10, 2010
Global histone acetylation levels: prognostic relevance in patients with renal cell carcinomaDavit Mosashvilli, Philip Kahl, Claudia Mertens, et al.
Epigenetics|October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
Anticancer Research|July 31, 2012
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancerSebastian Rogenhofer, Jörg Ellinger, Philip Kahl, et al.
World Journal of Urology|October 5, 2011
Tyrosine kinase expression profile in clear cell renal cell carcinomaTurang E Behbahani, Claudia Thierse, Claudia Baumann, et al.
Histology and Histopathology|September 8, 2025
CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomyElisabeth Dingendorf, Marit Bernhardt, Isabella Federica Bollen, et al.
AIDS Research and Therapy|January 5, 2013
A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analysesMaria M Prokofjeva, Kristoffer Riecken, Pavel V Spirin, et al.
Pageof 97

Showing results (711-720 of 963) with videos related to

Sort By:
Pageof 97
Infection and Immunity|June 11, 2014
A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypesConcerta Holley, Dharanesh Gangaiah, Wei Li, et al.
Wiener Klinische Wochenschrift|May 31, 2023
The history of circadian rhythm research in AustriaEva S Schernhammer, Gerhard Klösch, Isabella Ellinger, et al.
Infection and Immunity|May 1, 2019
A Class I <i>Haemophilus ducreyi</i> Strain Containing a Class II <i>hgbA</i> Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy TrialsIsabelle Leduc, Kate R Fortney, Diane M Janowicz, et al.
Urology|February 5, 2008
CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancerJörg Ellinger, Patrick J Bastian, Thomas Jurgan, et al.
Cancer Science|September 10, 2010
Global histone acetylation levels: prognostic relevance in patients with renal cell carcinomaDavit Mosashvilli, Philip Kahl, Claudia Mertens, et al.
Epigenetics|October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
Anticancer Research|July 31, 2012
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancerSebastian Rogenhofer, Jörg Ellinger, Philip Kahl, et al.
World Journal of Urology|October 5, 2011
Tyrosine kinase expression profile in clear cell renal cell carcinomaTurang E Behbahani, Claudia Thierse, Claudia Baumann, et al.
Histology and Histopathology|September 8, 2025
CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomyElisabeth Dingendorf, Marit Bernhardt, Isabella Federica Bollen, et al.
AIDS Research and Therapy|January 5, 2013
A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analysesMaria M Prokofjeva, Kristoffer Riecken, Pavel V Spirin, et al.
Pageof 97